Company announces 20% annual growth

MARLBOROUGH, Mass.-Friday 4 January 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- ExaGrid®, a leading provider of intelligent hyperconverged storage for backup, today announced record revenue for the full year of 2018. ExaGrid’s revenue grew 20% in 2018 over 2017. The company is growing faster than the overall market and continues to grow its market share position. Demonstrating growing demand on the part of enterprise IT environments for a superior solution that’s also cost effective, ExaGrid added over 100 new customers in the 4th quarter of 2018

“ExaGrid had an excellent year in North America, Latin America, EMEA and APAC,” said Bill Andrews, CEO and President of ExaGrid. “We are gaining momentum as our growth percentages demonstrate. In 2016, ExaGrid reported 12.2% growth; in 2017, 14.5%; and in 2018, 20%. The corporate goal is a growth rate of 25% in 2019 and 30% in 2020.” ExaGrid has co ... Read more »

New collaborations expand Takeda’s commitment to pursue the discovery of novel cell therapy approaches to treat blood cancers and solid tumors

CAMBRIDGE, Mass. & OSAKA, Japan-Friday 4 January 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502) today announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus for the company. Through these collaborations, Takeda seeks to accelerate the discovery of next-generation cancer immunotherapies, including novel cell therapy approaches that may provide important opportunities for addressing the needs of patients with hard-to-treat cancers.

“We are excited by the recent momentum in oncology R&D, especially around the curative potential of cell-based therapies through our growing partnership network,” said Phil Rowlands, Ph.D., Head, Oncology Therapeutic Area Unit, Takeda. “We look forward ... Read more »

 Coca-Cola Adds Global Coffee Platform with Potential for Future Growth and Expansion 

ATLANTA & DUNSTABLE, England-Friday 4 January 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- The Coca-Cola Company today announced that it has completed the acquisition of Costa Limited from Whitbread PLC. The $4.9 billion transaction follows approval from regulatory authorities in the European Union and China.

The acquisition was first announced on Aug. 31, 2018.

Costa, which has operations in more than 30 countries, gives Coca-Cola a significant footprint in the global coffee business. Worldwide, the coffee segment is growing 6% annually. Costa has a scalable platform across multiple formats and channels, from the existing Costa Express vending system to opportunities to introduce ready-to-drink products.

“We see great opportunities for value creation through the combination of Costa’s capabilities and Coca-Cola’s marketing expertise ... Read more »

•    Collaboration seeks to develop novel treatments for chronic liver diseases, including nonalcoholic steatohepatitis (NASH)

INGELHEIM, Germany & CAMBRIDGE, Mass.-Friday 4 January 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Boehringer Ingelheim and Dicerna Pharmaceuticals (NASDAQ: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that Boehringer Ingelheim has exercised an option to receive exclusive rights to a second hepatic disease target emerging from its research collaboration and license agreement with Dicerna. The collaboration, established in October 2017, aims to discover and develop novel GalXC™ RNAi therapeutics for the treatment of chronic liver diseases, with an initial focus on nonalcoholic steatohepatitis (NASH), a devastating disease for which there is no approved treatment.

The option is the second target under the two companies’ research collaboration and licens ... Read more »